Free from Publisher

Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis

SP Gampenrieder, F Romeder, C MUß… - Anticancer …, 2014 - ar.iiarjournals.org
Background: Several phase-III studies have shown improvements in terms of progression-
free survival (PFS) with bevacizumab when added to chemotherapy in advanced breast …
被引用次数：49 相关文章

Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis

SP Gampenrieder, F Romeder, C Muß… - Anticancer …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Several phase-III studies have shown improvements in terms of progression-
free survival (PFS) with bevacizumab when added to chemotherapy in advanced breast …
[PDF] iiarjournals.org

[PDF][PDF] Hypertension as a Predictive Marker for Bevacizumab in Metastatic Breast Cancer: Results from a Retrospective Matched-pair Analysis

S RESSLER, G RINNERTHALER… - ANTICANCER …, 2014 - ar.iiarjournals.org
Background: Several phase-III studies have shown improvements in terms of progression-
free survival (PFS) with bevacizumab when added to chemotherapy in advanced breast …

[引用][C] Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis.

SP Gampenrieder, F Romeder, C Muß… - ANTICANCER …, 2014 - pure.pmu.ac.at
Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from
a retrospective matched-pair analysis. — PMU Forschungsportal Zur Hauptnavigation …

Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis.

SP Gampenrieder, F Romeder, C Muß… - Anticancer …, 2014 - europepmc.org
Background Several phase-III studies have shown improvements in terms of progression-
free survival (PFS) with bevacizumab when added to chemotherapy in advanced breast …

[引用][C] Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis.

SP Gampenrieder, F Romeder, C Muß… - ANTICANCER …, 2014 - pure.pmu.ac.at
Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from
a retrospective matched-pair analysis. — PMU Research Portal Skip to main navigation Skip to …